Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis: Diagnosis and Treatment

Klinische Monatsblätter für Augenheilkunde
Brigitte WildemannSven Jarius

Abstract

Optic neuritis (ON) is a frequent manifestation of aquaporin-4 (AQP4) antibody-mediated neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (MOG-EM; also termed MOG antibody-associated disorders, MOGAD). The past few years have seen major advances in the diagnosis and treatment of these two relatively new entities: international diagnostic criteria for NMOSD and MOG-EM have been proposed, improved antibody assays developed, and consensus recommendations on the indications and methodology of serological testing published. Very recently, the results of four phase III trials assessing new treatment options for NMOSD have been presented. With eculizumab, a monoclonal antibody inhibiting complement factor C5, for the first time a relapse-preventing long-term treatment for NMOSD - which has so far mostly been treated off-label with rituximab, azathioprine, and other immunosuppressants - has been approved. Data from recent retrospective studies evaluating treatment responses in MOG-ON suggest that rituximab and other immunosuppressants are effective also in this entity. By contrast, many drugs approved for the treatment of multiple sclerosis (MS) have been found...Continue Reading

References

Sep 25, 1999·Neurology·D M WingerchukB G Weinshenker
Jun 22, 2002·Brain : a Journal of Neurology·Claudia F LucchinettiHans Lassmann
Aug 10, 2005·The Journal of Experimental Medicine·Vanda A LennonShannon R Hinson
Feb 3, 2006·Annals of Neurology·Brian G WeinshenkerVanda A Lennon
Mar 15, 2006·Archives of Neurology·Sean J PittockBrian G Weinshenker
May 24, 2006·Neurology·D M WingerchukB G Weinshenker
Jul 13, 2006·Archives of Neurology·Sean J PittockVanda A Lennon
Mar 13, 2008·Nature Clinical Practice. Neurology·Sven JariusBrigitte Wildemann
Apr 25, 2008·Neurology·M MatielloB G Weinshenker
Jul 20, 2010·Nature Reviews. Neurology·Sven Jarius, Brigitte Wildemann
May 23, 2012·Lancet Neurology·Marios C Papadopoulos, A S Verkman
May 30, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Silvio P NetoVera L R Pinto
Jul 11, 2012·Archives of Ophthalmology·Harold MerlePhilippe Cabre
Dec 22, 2012·Multiple Sclerosis : Clinical and Laboratory Research·K RostásyM Reindl
Jan 17, 2013·Journal of Neuroinflammation·Sven Jarius, Brigitte Wildemann
Jul 17, 2013·JAMA Neurology·Marcelo MatielloBrian G Weinshenker
Sep 7, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Marius RingelsteinPhilipp Albrecht
Jan 7, 2014·Advances in Immunology·Michael LevyOlaf Stuve
Apr 2, 2014·Acta Neuropathologica Communications·Samira SaadounMarios C Papadopoulos
Jun 21, 2015·Neurology·Dean M WingerchukUNKNOWN International Panel for NMO Diagnosis
Jul 15, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Sudarshini RamanathanRussell C Dale
Nov 6, 2015·Annals of Neurology·Ingo KleiterUNKNOWN Neuromyelitis Optica Study Group
Nov 26, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Ingo Kleiter, Ralf Gold
Nov 3, 2016·Journal of Neuroinflammation·Sven JariusUNKNOWN in cooperation with the Neuromyelitis Optica Study Group (NEMOS)
Dec 27, 2016·Neurology. Neuroimmunology and Neuroinflammation·Yukio TakeshitaRichard M Ransohoff
Mar 2, 2017·Current Opinion in Neurology·Markus ReindlThomas Berger
Mar 4, 2017·Neurology. Neuroimmunology and Neuroinflammation·Frederike C OertelAlexander U Brandt
Apr 6, 2017·Fortschritte der Neurologie-Psychiatrie·Florence PacheSven Jarius
May 26, 2017·Eye and Brain·Nilufer Kale
Aug 22, 2017·Multiple Sclerosis : Clinical and Laboratory Research·De-Cai TianFu-Dong Shi
Oct 17, 2017·Journal of Neurology, Neurosurgery, and Psychiatry·Mickael BonnanPhilippe Cabre
Nov 15, 2017·Brain : a Journal of Neurology·Maciej JurynczykJacqueline Palace
Nov 17, 2017·Journal of Neurology, Neurosurgery, and Psychiatry·Sudarshini RamanathanUNKNOWN Australasian and New Zealand MOG Study Group
Feb 14, 2018·Journal of Neurology, Neurosurgery, and Psychiatry·Masahiro MoriFriedemann Paul
Apr 7, 2018·Therapeutic Advances in Neurological Disorders·Martin S WeberWolfgang Brück

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.